February 14, 2018 / 1:22 PM / 3 months ago

BRIEF-Shire says too early to see impact Of Roche competitor Hemlibra

Feb 14 (Reuters) - Shire:

* CFO SAYS SEES IT IS STILL EARLY TO ASSESS IMPACT OF COMPETITOR ROCHE’S HEMLIBRA ON HEMOPHILIA FRANCHISE Further company coverage: (Reporting By London Bureau)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below